Skip to content
OpenCapital
Get started

Rani Therapeutics Holdings, Inc. RANI Q1 2026 earnings

Reported May 15, 2026 · Before market open

Revenue$1.7MBeat by $583.0K
EPS-$0.04Beat by $0.02
Revenue estimate$1.1M
EPS estimate-$0.06

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$925.0K
EPS estimate-$0.05

Versus estimates

Revenue

Q1 2026$1.7MBeat by $583.0K
Q4 2025$1.5MMiss by $3.5MQ1 2025$172.0KQ4 2024$1.0M

Diluted EPS

Q1 2026-$0.04Beat by $0.02
Q4 2025-$0.07Miss by $0.04Q3 2025-$0.12Miss by $0.03Q2 2025-$0.18Beat by $0.01Q1 2025-$0.22In lineQ4 2024-$0.27Miss by $0.03

Ask the moment Rani Therapeutics Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rani Therapeutics Holdings, Inc. report Q1 2026 earnings?
Rani Therapeutics Holdings, Inc. (RANI) reported Q1 2026 earnings on May 15, 2026 before market open.
What were Rani Therapeutics Holdings, Inc.'s Q1 2026 revenue and EPS?
Rani Therapeutics Holdings, Inc. reported revenue of $1.7M and eps of $-0.04 for Q1 2026.
Did Rani Therapeutics Holdings, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $1.1M by $583.0K. EPS beat the consensus estimate of $-0.06 by $0.02.
How did Rani Therapeutics Holdings, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 893.0% from $172.0K a year earlier and eps grew 81.8% from $-0.22.
Where can I find Rani Therapeutics Holdings, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-226691) and the 10-Q periodic report (0001193125-26-226703) directly on SEC EDGAR. The filing index links above go to sec.gov.